Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Malignant Lymphoma

  Free Subscription


05.01.2026

1 Am J Hematol
1 Blood
1 BMC Cancer
1 Bone Marrow Transplant
4 Br J Haematol
1 Cancer
2 Eur J Haematol
3 Haematologica
1 Hum Pathol
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Natl Cancer Inst
5 Leuk Lymphoma
1 PLoS One
1 Radiother Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. ALNUGHMUSH A, Atallah-Yunes SA, Hellou T, Habermann TM, et al
    Primary Breast MALT Lymphoma: Clinical Features and Outcomes From a Single-Institution Experience at Mayo Clinic.
    Am J Hematol. 2025 Dec 29. doi: 10.1002/ajh.70178.
    PubMed        


    Blood

  2. ABRAMSON JS, Straus DJ, Bartlett NL, Burke JM, et al
    Brentuximab Vedotin and Nivolumab in Combination With Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin Lymphoma.
    Blood. 2025 Dec 29:blood.2025030190. doi: 10.1182/blood.2025030190.
    PubMed         Abstract available


    BMC Cancer

  3. AN S, Hong J, Shin DY, Byun JM, et al
    Alternative splicing patterns in genetic subtypes of diffuse large B-cell lymphoma.
    BMC Cancer. 2025;25:1910.
    PubMed         Abstract available


    Bone Marrow Transplant

  4. PUCKRIN R, Sapon-Cousineau V, Peters A, Owen C, et al
    Real-world eligibility, utilization, and barriers to CAR T-cell therapy in relapsed/refractory mantle cell lymphoma.
    Bone Marrow Transplant. 2025 Dec 26. doi: 10.1038/s41409-025-02786.
    PubMed        


    Br J Haematol

  5. TERAO T, Yoshida I, Kobayashi H, Urata T, et al
    Efficacy and relapse profiles of Pola-R-CHP versus R-CHOP in previously untreated diffuse large B-cell lymphoma: A multicentre real-world study.
    Br J Haematol. 2025 Dec 26. doi: 10.1111/bjh.70280.
    PubMed         Abstract available

  6. ZILIOLI VR, Tucci A, Spina M, Merli F, et al
    The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.
    Br J Haematol. 2025 Dec 25. doi: 10.1111/bjh.70290.
    PubMed         Abstract available

  7. CHOY JP, Cheah CY
    T-cell/histiocyte-rich large B-cell lymphoma in the era of novel immunotherapy: A focused review.
    Br J Haematol. 2025 Dec 23. doi: 10.1111/bjh.70294.
    PubMed         Abstract available

  8. HUGUET M, Morgades M, Rivas-Delgado A, Bastos-Oreiro M, et al
    Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO.
    Br J Haematol. 2025 Dec 23. doi: 10.1111/bjh.70287.
    PubMed        


    Cancer

  9. YILMAZ U, Dal MS, Ulas T, Atesoglu EB, et al
    Exploring an independent association between rituximab-cyclophosphamide-doxorubicin-vincristine-prednisolone dose intensity and clinical outcomes in large B-cell lymphoma: Analyses of subsequent endpoints following a complete response in a real-world
    Cancer. 2026;132:e70248.
    PubMed         Abstract available


    Eur J Haematol

  10. MARTINO EA, Caserta S, Skafi M, Alvaro ME, et al
    Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based Approaches.
    Eur J Haematol. 2025 Dec 26. doi: 10.1111/ejh.70105.
    PubMed         Abstract available

  11. CASERTA S, Martino EA, Skafi M, Alvaro ME, et al
    Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune Strategies.
    Eur J Haematol. 2025 Dec 25. doi: 10.1111/ejh.70101.
    PubMed         Abstract available


    Haematologica

  12. TERAKAWA T, Fuji S, Shi H, Amemiya Y, et al
    Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy.
    Haematologica. 2025 Dec 24. doi: 10.3324/haematol.2025.289269.
    PubMed         Abstract available

  13. LEE D, Dahiya S
    Mapping the immune orchestra of zamtocabtagene autoleucel in primary CNS lymphoma.
    Haematologica. 2025 Dec 24. doi: 10.3324/haematol.2025.289294.
    PubMed         Abstract available

  14. MARCUS R, Avigdor A, Greenbaum U, Brown S, et al
    Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysis.
    Haematologica. 2025 Dec 24. doi: 10.3324/haematol.2025.288419.
    PubMed         Abstract available


    Hum Pathol

  15. YU M, Zeng X, Luo W, Huang Q, et al
    Granulomatous variant of extranodal NK/T-cell lymphoma: Mimicking inflammatory or infective lesions.
    Hum Pathol. 2025;168:106027.
    PubMed         Abstract available


    Int J Cancer

  16. ROSTGAARD K, Hamilton-Dutoit S, Lauridsen KL, Ottander L, et al
    Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.
    Int J Cancer. 2025 Dec 25. doi: 10.1002/ijc.70305.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  17. LO AC, Milgrom SA, Vega RM, Hodgson D, et al
    Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131.
    Int J Radiat Oncol Biol Phys. 2025 Dec 24:S0360-3016(25)06596.
    PubMed         Abstract available


    J Clin Oncol

  18. KRUPKA JA, Moutsopoulos I, Cutmore NH, Trethewey CS, et al
    Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.
    J Clin Oncol. 2025 Dec 22:JCO2501587. doi: 10.1200/JCO-25-01587.
    PubMed         Abstract available


    J Natl Cancer Inst

  19. HEMMINGSEN CH, Morch LS, Arvedsen J, Dahl EO, et al
    Hormonal contraception and lymphoma risk in danish women 15-49 years: a nationwide cohort study.
    J Natl Cancer Inst. 2025 Dec 22:djaf371. doi: 10.1093.
    PubMed         Abstract available


    Leuk Lymphoma

  20. GRIBBEN JG, Palomba ML, Limbrick-Oldfield E, Palivela M, et al
    Axicabtagene ciloleucel demonstrates superior outcomes over historically available treatments in relapsed/refractory follicular lymphoma: 5-year comparative analysis between ZUMA-5 and SCHOLAR-5.
    Leuk Lymphoma. 2025 Dec 30:1-5. doi: 10.1080/10428194.2025.2604306.
    PubMed        

  21. VITHANAGE PG, Rafiq M, Drosdowsky A, Ramsay G, et al
    Time to diagnosis and treatment in lymphoma and implications for health-related outcomes: a systematic review.
    Leuk Lymphoma. 2025 Dec 30:1-25. doi: 10.1080/10428194.2025.2598663.
    PubMed         Abstract available

  22. MOHAMMED SALEH MF, Kotb A, Alamer A, Albabtain AA, et al
    T-cell/histiocyte-rich large B-cell lymphoma, insights into prognosis and treatment complexity in the context of immunotherapeutics.
    Leuk Lymphoma. 2025 Dec 29:1-7. doi: 10.1080/10428194.2025.2607549.
    PubMed         Abstract available

  23. STAFYLIDIS C, Lakiotaki E, Rougala N, Giannakopoulou N, et al
    Reclassifying T-cell lymphomas in human T-lymphotropic virus 1 carriers: a familial case of adult T-cell leukemia/lymphoma with diagnostic and pathogenetic implications.
    Leuk Lymphoma. 2025 Dec 25:1-5. doi: 10.1080/10428194.2025.2606948.
    PubMed        

  24. MATSUMOTO S, Kurihara Y, Masuda Y, Nara K, et al
    Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphoma.
    Leuk Lymphoma. 2025 Dec 22:1-9. doi: 10.1080/10428194.2025.2604305.
    PubMed         Abstract available


    PLoS One

  25. NAKAMURA M, Matsumoto Y, Nagata M, Yasuda K, et al
    Exploring DNA methylation profiles in blood samples of canine gastrointestinal lymphoma.
    PLoS One. 2025;20:e0339388.
    PubMed         Abstract available


    Radiother Oncol

  26. ATTILI A, Algranati C, Cianchetti M, Giacomelli I, et al
    A dedicated MKM-based radiobiological model for secondary cancer estimation in charged particle radiotherapy: An application in lymphomas and breast proton therapy.
    Radiother Oncol. 2026;214:111229.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.